Literature DB >> 15877739

Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease.

Paul Woodard1, Kathleen J Helton, Raja B Khan, Gregory A Hale, Sean Phipps, Winfred Wang, Rupert Handgretinger, John M Cunningham.   

Abstract

Prospective magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), neuropsychological testing and neurological examinations were performed to determine the long-term effect of successful haematopoietic stem cell transplantation on the neurological status of nine children with sickle cell disease. A scoring system for severity of brain parenchymal and vascular lesions was developed and applied. Neurological examinations and neuropsychometric tests were stable, but MRI and MRA studies were not. Transient changes occurred early in two patients. Persistent changes occurred in five. Parenchymal lesions occurred in zero of two patients without prior lacunae or infarcts and in all seven with prior lacunae or infarcts (P = 0.0278).

Entities:  

Mesh：

Year:  2005        PMID： 15877739     DOI： 10.1111/j.1365-2141.2005.05491.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


  13 in total

Review 1.  The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease.

Authors:  John J Strouse; Sophie Lanzkron; Victor Urrutia
Journal:  Expert Rev Hematol       Date:  2011-12       Impact factor: 2.929

2.  Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.

Authors:  Nancy S Green; Monica Bhatia; Erica Y Griffith; Mahvish Qureshi; Courtney Briamonte; Mirko Savone; Stephen Sands; Margaret T Lee; Angela Lignelli; Adam M Brickman
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-09       Impact factor: 5.742

3.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

4.  Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.

Authors:  Erin M Hall; Jeffrey Leonard; Jodi L Smith; Kristin P Guilliams; Michael Binkley; Robert J Fallon; Monica L Hulbert
Journal:  Pediatr Blood Cancer       Date:  2016-04-22       Impact factor: 3.167

5.  Long-term outcome and evaluation of organ function in pediatric patients undergoing haploidentical and matched related hematopoietic cell transplantation for sickle cell disease.

Authors:  Mari H Dallas; Brandon Triplett; David R Shook; Christine Hartford; Ashok Srinivasan; Joseph Laver; Russell Ware; Wing Leung
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-14       Impact factor: 5.742

Review 6.  Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease.

Authors:  Hitomi Hosoya; Jeffrey Levine; Peter Abt; David Henry; David L Porter; Saar Gill
Journal:  Blood Adv       Date:  2018-03-13

7.  Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601.

Authors:  Allison A King; Robert C McKinstry; Juan Wu; Mary Eapen; Regina Abel; Taniya Varughese; Naynesh Kamani; Shalini Shenoy
Journal:  Biol Blood Marrow Transplant       Date:  2019-01-11       Impact factor: 5.742

Review 8.  Current concepts in the management of stroke in children with sickle cell disease.

Authors:  M S Islam; P Anoop
Journal:  Childs Nerv Syst       Date:  2011-01-22       Impact factor: 1.475

9.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

Review 10.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.